Hormonally active adrenocortical carcinoma and its porphyrin content
Szklarz, E.; Zawirska, B.; Gruszka, S.; Plamieniak, Z.; Wrezlewicz, W.; Moszczyński, L.; Dzik, T.
Endokrynologia Polska 29(1): 53-61
1978
ISSN/ISBN: 0423-104X PMID: 648468 Document Number: 126959
Document emailed within 1 workday
Related Documents
Edgren, M.; Eriksson, B.; Wilander, E.; Westlin, J.E.; Nilsson, S.; Oberg, K. 1997: Biological characteristics of adrenocortical carcinoma: a study of p53, IGF, EGF-r, Ki-67 and PCNA in 17 adrenocortical carcinomas Anticancer Research 17(2b): 1303-1309Enikeev, R.G. 1971: Hormonally-active tumors of the testes in children Pediatriia 50(9): 91
Gawdzińska-Grabowska, H. 1982: Case of hormonally active parathyroid adenoma Polski Tygodnik Lekarski 37(1): 17-18
Kozachenko, V.P.; Adamian, R.T.; Pichugina, M.N.; Filatova, A.M. 1981: Malignancy of hormonally active ovarian tumors Voprosy Onkologii 27(10): 40-44
Dehne, A.; Kunze, K.D. 1986: Hormonally active parathyroid gland cancer. Case report Zentralblatt für Chirurgie 111(14): 870-873
Kajta, Młgorzata.; Wójtowicz, A. 2010: Neurodevelopmental disorders in response to hormonally active environmental pollutants Przeglad Lekarski 67(11): 1194-1199
Komissarenko, I.V.; Rybakov, S.I. 1984: Procedural and technical aspects of the surgical treatment of hormonally active adrenal tumors Klinicheskaia Khirurgiia 12: 5-6
Klein, C.P. 1976: The hormonally active pancreatic neoplasms. Occurrence, clinical symptoms, the diagnosis and therapeutic possibilities Medizinische Klinik 71(8): 344-349
Zurbrügg, R.P.; Wagner, H.P. 1970: Interrelations between hormonally active tumors and sexual precocity. A brief discussion basing on six illustrative case histories Helvetica Paediatrica Acta 25(2): 99-113
Zielińska, D.; Rzepka-Górska, I. 2012: Features of pubescence in patients with pure gonadal dysgenesis in the course of a hormonally active tumor--case report Ginekologia Polska 83(7): 549-551
Sassaroli, M.; da Costa, R.; Väänänen, H.; Eisinger, J.; Poh-Fitzpatrick, M.B. 1992: Distribution of erythrocyte free porphyrin content in erythropoietic protoporphyria Journal of Laboratory and Clinical Medicine 120(4): 614-623
DeKernion, J.B.; Lindner, A. 1984: Chemotherapy of hormonally unresponsive prostatic carcinoma Urologic Clinics of North America 11(2): 319-326
Dobrotina, N.A.; Krivosheev, B.N. 1974: Content and functional activity of serum proteins and certain problems of pathogenesis of dermatoses with disorders of porphyrin metabolism Vestnik Dermatologii i Venerologii 48(3): 42-48
Curnow, A.; Pye, A. 2007: Biochemical manipulation via iron chelation to enhance porphyrin production from porphyrin precursors Journal of Environmental Pathology Toxicology and Oncology: Official Organ of the International Society for Environmental Toxicology and Cancer 26(2): 89-103
Schermuly, E.; Doss, M. 1976: Porphyrin biosynthesis from ALA and PBG by human erythrocytes in porphyrin disorders. Kinetic studies of the isomer series i and IIi Annals of Clinical Research 8(Suppl 17): 92-102
Shliapnikova, E.A.; Savitskiĭ, A.P.; Kachalova, G.S. 1986: Accessibility of porphyrin macrocycle in myoglobin at various pH levels. Fluorescence study of the porphyrin-globin complex Molekuliarnaia Biologiia 20(1): 138-145
Gayot, A.; Blouet, E.; Leterme, P.; Traisnel, M. 1988: Study of content and uniformity of content of tablets prepared with a low concentration in active ingredient Bollettino Chimico Farmaceutico 127(9-10): 218-220
Jani, P.; Nasr, A.Lotfy.; Demellawy, D.El. 2008: Synchronous renal cell carcinoma and adrenocortical carcinoma: a rare case report and clinicopathologic approach Canadian Journal of Urology 15(2): 4016-4019
Ichikawa, T.; Ito, H. 2001: Adrenocortical carcinoma Nihon Rinsho. Japanese Journal of Clinical Medicine 59(Suppl 7): 393-400
Decker, R.A.; Kuehner, M.E. 1991: Adrenocortical carcinoma American Surgeon 57(8): 502-513